Cogentia

Cambridge, United Kingdom Founded: 2010 • Age: 16 yrs Acquired By Helios Global Group
Healthcare consulting company specializing in market access and health economics within the life sciences industry
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Cogentia

Cogentia is a company based in Cambridge (United Kingdom) founded in 2010 by James Morris was acquired by Helios Global Group in February 2024. Cogentia operates in a competitive market with competitors including Sayre Therapeutics, Zevra, Supreme Optimization, Ethosh and Life Science Connect, among others.

  • Headquarter Cambridge, United Kingdom
  • Founders James Morris
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Helios Global Group

    (Feb 13, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Cogentia

Premium access

Detailed funding history for Cogentia

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Cogentia

Cogentia has secured backing from 1 investor. Prominent investors backing the company include Helios Global Group.

All
Investor Description Founded Year Domain Location
Branding and medical communication consulting services are provided globally.
Locked Locked Locked
Premium access

Investor details for Cogentia

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Cogentia

Investments
Premium access

Investment portfolio details for Cogentia

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Cogentia

Premium access

Detailed financials for Cogentia

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cogentia Comparisons

Cogentia Primary company
Description
Healthcare consulting company specializing in market access ...
Location
Cambridge, United Kingdom
Founded Year
2010
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Cogentia

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Cogentia

Cogentia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sayre Therapeutics, Zevra, Supreme Optimization, Ethosh and Life Science Connect, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Access to therapies for rare and life-threatening diseases is provided.
Locked Locked Locked
Marketing services are provided to biopharma companies.
Locked Locked Locked
Digital marketing services are offered to the life sciences sector.
Locked Locked Locked
Provider of digital experience and marketing services to health-tech and life-sciences organizations
Locked Locked Locked
Marketing and commercialization services for biopharma sector are provided.
Locked Locked Locked
Prescription pharmaceuticals are acquired, licensed, and commercialized by the company.
Premium access

Detailed competitors of Cogentia

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cogentia

Premium access

Complete news archive for Cogentia

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cogentia

Cogentia was founded in 2010.

Cogentia is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Cogentia was founded in 2010 and is based in Cambridge, United Kingdom. Operations focus on healthcare consulting within the life sciences industry. Services provided include landscape assessments, value proposition development, and pricing and reimbursement strategies. Expertise is applied to market access and health economics challenges faced by clients in this sector.

Cogentia's top competitors include Zevra, Knight Therapeutics and Sayre Therapeutics.

Cogentia has 1 investor. Key investors include Helios Global Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available